Literature DB >> 8688972

Loss of GLUT2 glucose transporter expression in pancreatic beta cells from diabetic Chinese hamsters.

A Jörns1, M Tiedge, E Sickel, S Lenzen.   

Abstract

The diabetic Chinese hamster is a well-established animal model for NIDDM with a defective glucose-induced insulin secretory response. In the pancreas of nondiabetic hamsters, the GLUT2 glucose transporter was localized in the plasma membrane of insulin-positive beta cells. At variance with the rat, immunoreactivity was also detected in the cytoplasm. Other islet cell types were not GLUT2 positive. GLUT2 immunoreactivity was already significantly reduced in beta cells from mildly diabetic animals in spite of a normal insulin immunoreactivity. In severely diabetic animals the majority of the beta cells had lost GLUT2 immunostaining. This observation was confirmed in a Western blot analysis of the GLUT2 protein in isolated pancreatic islets. Only beta cells that were densely immunostained for insulin were still GLUT2 positive. However, around 40% of the beta cells devoid of GLUT2 immunoreactivity were still insulin immunoreactive. Thus, the loss of GLUT2 immunoreactivity, which is an important component of the glucose recognition apparatus of the pancreatic beta cell, is an early indicator of beta cell dysfunction before the development of degenerative lesions or the loss of insulin immunoreactivity. GLUT2 loss may be important in the deterioration of glucose-induced insulin secretion in the diabetic Chinese hamster.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688972     DOI: 10.1007/bf00200660

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  32 in total

1.  Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes.

Authors:  J H Johnson; A Ogawa; L Chen; L Orci; C B Newgard; T Alam; R H Unger
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.

Authors:  L Orci; M Ravazzola; D Baetens; L Inman; M Amherdt; R G Peterson; C B Newgard; J H Johnson; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 3.  Pancreatic beta cells in insulin-dependent diabetes.

Authors:  D Pipeleers; Z Ling
Journal:  Diabetes Metab Rev       Date:  1992-10

4.  Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells.

Authors:  B Thorens; H K Sarkar; H R Kaback; H F Lodish
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

5.  Studies in the diabetic Chinese hamster: light microscopy and autoradiography of pancreatic islets.

Authors:  A A Like; G C Gerritsen; W E Dulin; P Gaudreau
Journal:  Diabetologia       Date:  1974-11       Impact factor: 10.122

6.  Characterization of diabetes in the Chinese hamster.

Authors:  G C Gerritsen; W E Dulin
Journal:  Diabetologia       Date:  1967-04       Impact factor: 10.122

7.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

8.  Immunocytochemical and ultrastructural heterogeneities of normal and glibenclamide stimulated pancreatic beta cells in the rat.

Authors:  A Jörns
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Impaired beta-cell function in the Chinese hamster CHIG/Han subline.

Authors:  K D Kohnert; B Hehmke; W Besch; J Kessler; I Klöting
Journal:  Exp Clin Endocrinol Diabetes       Date:  1995       Impact factor: 2.949

10.  Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.

Authors:  C Chen; B Thorens; S Bonner-Weir; G C Weir; J L Leahy
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

View more
  6 in total

1.  Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction.

Authors:  H S Jürgens; S Neschen; S Ortmann; S Scherneck; K Schmolz; G Schüler; S Schmidt; M Blüher; S Klaus; D Perez-Tilve; M H Tschöp; A Schürmann; H-G Joost
Journal:  Diabetologia       Date:  2007-04-17       Impact factor: 10.122

2.  Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.

Authors:  Anna Benrick; Belén Chanclón; Peter Micallef; Yanling Wu; Laila Hadi; John M Shelton; Elisabet Stener-Victorin; Ingrid Wernstedt Asterholm
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-08       Impact factor: 11.205

3.  20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT/GSK-3β/Glut2 pathway.

Authors:  Bijun Zhang; Guangrui Lai; Jingjing Wu; Ru Sun; Runhong Xu; Xianghong Yang; Yafei Qi; Yanyan Zhao
Journal:  Endocrine       Date:  2016-08-27       Impact factor: 3.633

4.  Islet Hypersensitivity to Glucose Is Associated With Disrupted Oscillations and Increased Impact of Proinflammatory Cytokines in Islets From Diabetes-Prone Male Mice.

Authors:  Kathryn L Corbin; Christopher D Waters; Brett K Shaffer; Gretchen M Verrilli; Craig S Nunemaker
Journal:  Endocrinology       Date:  2016-03-04       Impact factor: 4.736

5.  Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure.

Authors:  O Kluth; F Mirhashemi; S Scherneck; D Kaiser; R Kluge; S Neschen; H-G Joost; A Schürmann
Journal:  Diabetologia       Date:  2010-11-24       Impact factor: 10.122

6.  Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function.

Authors:  Liad Hinden; Majdoleen Ahmad; Sharleen Hamad; Alina Nemirovski; Gergő Szanda; Sandra Glasmacher; Aviram Kogot-Levin; Rinat Abramovitch; Bernard Thorens; Jürg Gertsch; Gil Leibowitz; Joseph Tam
Journal:  Nat Commun       Date:  2022-04-04       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.